No loss of demand for Ryman

Demand to live in Ryman Healthcare’s villages remains strong with new residents looking for the security and certainty that purpose-built Ryman communities offer during COVID, shareholders were told today. “We’ve reviewed progress and we are pleased with where we are...

Cooks Coffee pours a strong quarter

28.7.22 Cooks Coffee Company reports that for the first 3 months of its financial year (April-June 2022) group store sales of its core businesses - Esquires UK Esquire Ireland and award-winning Triple Two UK - are up +90% compared to the same period last year and +34%...

AFT Pharma resets on US after setback

27.7.22 AFT Pharmaceuticals’ Pascomer clinical study in the US has been completed and not with the outcome hoped. The medicine did not reach the threshold on the IGA scale that the US Food and Drug Administration (FDA) considered necessary for its registration in the...

AFT director Dr Doug Wilson stepping down

27.7.22 AFT Pharmaceuticals (NZX: AFT, ASX: AFP) today announced that Dr Doug Wilson will step down from its board of Directors at the conclusion of the company’s annual meeting on 5 August 2022. Dr Wilson joined the AFT board in 2012 following a distinguished and...

Tough half-year for F&C

26.7.22   With equities declining into a ‘bear market’, defined as a fall from the peak of over 20%, F&C Investment delivered a Net Asset Value (‘NAV’) total return of -9.6% for the half-year ended June 30. The benchmark FTSE All-World Index, fell by 10.7%....